BioHistory Moment: Food Additives Amendments passed
On September 6, 1958, The Food Additives Amendments were passed, requiring that food
additives, including preservatives, emulsifiers, and other functional additives,
be subject to premarket testing.
Today, the FDA must review the safety of food and color additives before manufacturers
and distributors can market them. To initiate this review, the FDA requires sponsors
to submit a petition or notification that includes test data demonstrating the
safety of the intended use of the substance.
 More...
Learn about Seattle's PNDRI Life Sciences Incubator Building
A contemporary-designed building provided with modern research systems. Four floors are specifically laboratory space, one floor is a
fully equipped vivarium and one floor is clinical space and management offices.
Learn about biotechnology, medical device and pharmaceutical facilities available for sale,
lease or sublease in British Columbia, regionally or nationwide.
More...
(Advertising)
|
|
|
Industry News...
Free News Release Posting & Archiving Service
- Mayo Clinic study finds mild cognitive impairment is more common in men A Mayo Clinic study found that the prevalence of mild cognitive impairment was 1.5 times higher in men than in women. The research also showed a prevalence rate of 16 percent in the population-based study of individuals aged 70-89 without dementia who live in Olmsted County, Minn.
Mayo Clinic September 06, 2010
- MedImmune receives complete response letter on motavizumab MedImmune announced that it has received a second complete response letter on motavizumab from the FDA which requested evidence from an additional clinical trial that supports a satisfactory risk/benefit profile in the population(s) for which the prophylaxis indication is being requested.
MedImmune, LLC. September 05, 2010
- European Commission issues positive decision for approval of Seroquel XR AstraZeneca announced the European Commission issued a positive decision for the approval of once-daily SEROQUEL XR Extended Release Tablets as an add-on treatment of major depressive episodes in patients with Major Depressive Disorder who had sub-optimal response to antidepressant monotherapy.
AstraZeneca September 02, 2010
- New England Journal of Medicine reports Xpert MTB/RIF a faster Tuberculosis test New England Journal of Medicine reports Xpert MTB/RIF a faster, more Cepheid announced that its Xpert(R) MTB/RIF test was the subject of a study published in the latest edition of the New England Journal of Medicine (NEJM), "Rapid Molecular Detection of Tuberculosis and Rifampin Resistance."
Cepheid September 02, 2010
- Oncolytics Biotech® announces randomized phase II ovarian cancer study Oncolytics Biotech announced that the Gynecologic Oncology Group (GOG) intends to conduct a randomized Phase II trial of weekly paclitaxel versus weekly paclitaxel with REOLYSIN® in patients with persistent or recurrent, ovarian, fallopian tube or primary peritoneal cancer (GOG186H).
Oncolytics Biotech® Inc. September 02, 2010
More... | Submit News Release | Advertising...
|
New Job Postings...
Free Job Posting Trial Offer
More... |
Job Advertising...
| About Job Postings...
|
New Facilities Available...
ATC clean room constructors...validation guaranteed!
More... |
Facility Advertising...
|
Upcoming Events...
 More... |
Submit Event |
Event Advertising...
|
|
Learn About British Columbia's BioHistory
Why is there a life science industry in British Columbia? Is the industry
growing? What do other states have?
Through British Columbia BioHistory, you can learn about the scientists,
institutions, political leaders, and significant events that have shaped and are still shaping
the biotechnology, medical device and life science industry in British Columbia.
More...
BioEvolution Posters
More...
September: Ovarian Cancer Awareness Month
In women age 35-74, ovarian cancer is the fifth leading cause of cancer-related deaths.
An estimated one woman in 58 will develop ovarian cancer during her lifetime. The
American Cancer Society estimates that in 2008, there will be 21,650 new cases of
ovarian cancer and 15,520 women will die from ovarian cancer.
The National Ovarian Cancer Coalition (NOCC) is dedicated to raising awareness and
increasing education about ovarian cancer. Established in 1995, the organization is
committed to improving the survival rate and quality of life for women with this cancer.
More...
BioFact
(1919) - Hungarian Kark Ereky coins the term biotechnology to describe the interaction of biology with technology.
It's a Small World
|
| |
Yersinia Pestis (Fluorescent)
| |
Science Quote
"The mathematical sciences particularly exhibit order, symmetry, and limitation; and these are the greatest forms of the beautiful."
| - |
Aristotle, Greek philosopher
|
|
(384-322 BC)
|
|
